Can glycoprofiling be helpful in detecting prostate cancer?

Chemical Papers

Volumn 69, Issue 1, 2015, Pages 90-111

  Belicky, Stefan ^a   Tkac, Jan ^a  

^a Slovak Academic of Sciences   (Slovakia)

Author keywords

biomarkers; biosensors; electrochemical impedance spectroscopy; glycans; lectins; prostate cancer

Indexed keywords

EID: 84916898906     PISSN: 03666352     EISSN: 13369075     Source Type: Journal    
DOI: 10.1515/chempap-2015-0052     Document Type: Review

References (191)

1. Abd Hamid, U.M., Royle, L., Saldova, R., Radcliffe, C. M., Harvey, D. J., Storr, S. J., Pardo, M., Antrobus, R., Chapman, C. J., Zitzmann, N., Robertson, J. F., Dwek, R. A., & Rudd, P. M. (20 08). A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression. Glycobiology, 18, 1105-1118. DOI: 10.1093/glycob/cwn095.
2. Ablin, R. J., Pfeiffer, L., G onder, M. J., & Soanes, W. A. (1969). Precipitating antibody in the sera of patients treated cryosurgically for carcinoma of the prostate. Experimental medicine and surgery, 27, 406-410.
3. Albertsen, P. C., Hanley, J. A., Gleason, D. F., & Barry, M. J. (1998). Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. Jama, 280, 975-980. DOI: 1 0.1001/jama.280.11.975.
4. Alley, W. R., Mann, B. F., & Novotny, M. V. (2013). Highsensitivity analytical approaches for the structural characterization of glycoproteins. Chemical Reviews, 113, 2668-2732. DOI: 10.1021/cr3003714.
5. An, H. J., Froehlich, J. W., & Lebrilla, C. B. (2009). Determination of glycosylation sites and site-specific heterogeneity in glycoproteins. Current Opinion in Chemical Biology, 13, 421-426. DOI: 10.1016/j.cbpa.2009.07.022.
6. Andersen, C. B. F., Torvund-Jensen, M., Nielsen, M. J., De Oliveira, C. L. P., Hersleth, H. P., Andersen, N. H., Pedersen, J. S., Andersen, G. R., & Moestrup , S. K. (2012). Structure of the haptoglobin-haemoglobin complex. Nature, 489, 456-459. DOI: 10.1038/nature11369.
7. Andre, S., Wang, G. N., Gabius, H. J., & Murphy, P. V. (2014). Combining glycoclust er synthesis with protein engineering: An approach to probe into the significance of linker length in a tandem-repeat-type lectin (galectin-4). Carbohydrate Research, 389, 25-38. DOI: 10.1016/j.carres.2013.12.024.
8. Anthony, R. M., Nimmerjahn, F., Ashline, D. J., Reinhold, V. N., Paulson, J. C., & Ravetch, J. V. (2008). Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science, 320, 373-376. DOI : 10.1126/science.1154315.
9. Arnaud, J., Audfray, A., & Imberty, A. (2013). Binding sugars: From natural lectins to synthetic receptors and engineered neolectins. Chemical Society Reviews, 42, 4798-4813. DOI: 10.1039/c2cs35435g.
10. Arnold, J. N., Saldova, R., Galligan, M. C., Murphy, T. B., Mimura-Kimura, Y., Telford, J. E., Godwin, A. K., & Rudd, P. M. (2011). Novel glycan biomarkers for the detection of lung c ancer. Journal of Proteome Research, 10, 1755-1764. DOI: 10.1021/pr101034t.
11. Arthur, C. M., Cummings, R. D., & Stowell, S. R. (2014). Using glycan microarrays to understand immunity. Current Opinion in Chemical Biology, 18, 55-61. DOI: 10.1016/j.cbpa. 2013.12.017.
12. Ates, M. (2011). Review study of electrochemical impedance spectroscopy and equivalent electrical circuits of conducting polymers on carbon surfaces. Progr ess in Organic Coatings, 71, 1-10. DOI: 10.1016/j.porgcoat.2010.12.011.
13. Badr H. A. AlSadek D. M. M. Darwish A. A. ElSayed A. I. Bekmanov B. O. Khussainova E. M. Zhang X. J. Cho W. C. S. Djansugurova, L. B.,Li, C. Z. 2014Lectin approaches for glycoproteomics in FDA-approved cancer biomarkers. Expert Review of Proteomics, 11, 227-236. DOI: 10.1586/14789450.2014.897611.
14. Baker, J. L., C? elik, E., & DeLisa, M. P. (2013). Expanding the glycoengineering toolbox: The rise of bact erial N-linked protein glycosylation. Trends in Biotechnology, 31, 313-323. DOI: 10.1016/j.tibtech.2013.03.003.
15. Balk, S. P., Ko, Y. J., & Bubley, G. J. (2003). Biology of prostate-specific antigen. Journal of Clinical Oncology, 21, 383-391. DOI: 10.1200/jco.2003.02.083.
16. Barfidokht, A., & Gooding, J. J. (2014). Approaches toward allowing electroanalytical devices to be used in biological fluids. Electroanalysis, 26, 1182 -1196. DOI: 10.1002/elan.201400 097.
17. Barkalina, N., Charalambous, C., Jones, C., & Coward, K. (2014). Nanotechnology in reproductive medicine: Emerging applications of nanomaterial s. Nanomedicine: Nanotechnology, Biology and Medicine, 10, 921-938. DOI: 10.1016/j.nano.2014.01.001.
18. Berry, S. J., Coffey, D. S., Walsh, P. C., & Ewing, L. L. (1984). The development of human benign prostatic hyperplasia with age. The Journal of Urology, 132, 474-479.
19. Bertok, T., Katrlik, J., Gemeiner, P., & Tkac, J. (2013a). Electrochemical lectin based biosensors as a label-free tool in glycomic s. Microchimica Acta, 180, 1-13. DOI: 10.1007/s00604-012-0876-4.
20. Bertok, T., Klukova, L., Sediva, A., Kasak, P., Semak, V., Micusik, M., Omastova, M., Chovanova, L., Vl?ek, M., Imr ich, R., Vikartovska, A., & Tkac, J. (2013b). Ultrasensitive impedimetric lectin biosensors with efficient antifouling properties applied in glycoprofiling of human serum samples. Analytical Chemistry, 85, 7324-7332. DOI: 10.1021/ac40 1281t.
21. Bertok, T., Sediva, A., Katrlik, J., Gemeiner, P., Mikula, M., Nosko, M., & Tkac, J. (2013c). Label-free detection of glycoproteins by the lectin biosensor down to attomolar level using gold nanopartic les. Talanta, 108, 11-18. DOI: 10.1016/j.talanta.2013.02.052.
22. Bertok, T., Sediva, A., Vikartovska, A., & Tkac, J. (2014). Comparison of the 2d and 3d nanostructured lectin-based biosensors for in s itu detection of sialic acid on glycoproteins. International Journal of Electrochemical Science, 9, 890-900.
23. Bo, M., Ventura, M., Marinello, R., Capello, S., Casetta, G., & Fabris, F. (2003). Relationship between prostatic specific antigen (PSA) and volume of the prostate in the benign prostatic hyperplasia in the elderly. Critical Reviews in Oncology/Hematology, 47, 207-211. DOI: 10.1016/s1040-8428(03)00094-5.
24. Boron, W. F., & Boulpaep, E. L. (2009). Medical physiology: A cellular and molecular approach. Philadelphia, PA, USA: Saunders/Elsevier.
25. Borrebaeck, C. A. K., & Wingren, C. (2011). Recombinant antibodies for the generation of antibody arrays. Methods in Molecular Biology, 785, 247 -262. DOI: 10.1007/978-1-61779-286-1 17.
26. Bostwick, D. G., Pacelli, A., Blute, M., Roche, P., & Murphy, G. P. (1998). Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: A study of 184 cases. Cancer, 82, 2256-2261. DOI: 10.1002/(sici)1097-0142(19980601)82:11 3.0. co;2-s.
27. Briand, E., Salmain, M., Compère, C., & Pradier, C. M. (2006). Immobilization of protein A on SAMs for the elaboration of immunosensors. Colloids and Surfaces B: Biointerfaces, 53, 215-224. DOI: 10.1016 /j.colsurfb.2006.09.010.
28. Bu?ko, M., Mislovi?ova, D., Nahalka, J., Vikartovska, A., Šef?ovi?ova, J., Katrlik, J., Tkac, J., Gemeiner, P., Lacik, I., Štefuca, V., Polakovi?, M., Rosenberg, M., Rebro?, M., Š mogrovi?ova, D., & Švitel, J. (2012). Immobilization in biotechnology and biorecognition: From macro-to nanoscale systems. Chemical Papers, 66, 983-998. DOI: 10.2478/s11696-012-0226-3.
29. Burton, D. R., Poignard, P., Stanfield, R. L., & Wilson, I. A. (2012). Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses. Science, 337, 183-186. DOI: 10.1126/science.1225416.
30. Byrne, H., Conroy, P. J., Whiss tock, J. C., & O'Kennedy, R. J. (2013). A tale of two specificities: Bispecific antibodies for therapeutic and diagnostic applications. Trends in Biotechnology, 31, 621-632. DOI: 10.1016/j.tibtech.2013.08.007.
31. Cancino, J., & Machado, S. A. S. (2012). Microelectrode array in mixed alkanethiol self-assembled monolayers: Electrochemical studies. Electrochimica Acta, 72, 108-113. DOI: 10.1016/j.electacta.2012.04.009.
32. Cat alona, W. J., Smith, D. S., Ratliff, T. L., Dodds, K. M., Coplen, D. E., Yuan, J. J. J., Petros, J. A., & Andriole, G. L. (1991). Measurement of prostate-specific antigen in serum as a screening test for prostate c ancer. New England Journal of Medicine, 324, 1156-1161. DOI: 10.1056/nejm199104253241702.
33. Chen, J R., Miao, Y. Q., He, N. Y., Wu, X. H., & Li, S. J. (2004). Nanotechnology and biosensors. Biotechnology Advances, 22, 505-518. DOI: 10.1016/j.biotechadv.2004.03.004.
34. Chen S. H. Yuan R. Chai Y. Q. Min L. G. Li W. J.Xu Y. 2009 Electrochemical sensing platform b ased on tris(2,2--bipyridyl)cobalt(III) and multiwall carbon nanotubes-Nafion composite for immunoassay of carcinoma antigen-125. Electrochimica Acta 54 7242-7247 10.1016/j.electacta.2009.07.035.
35. Chornokur, G., Arya, S. K., Phelan, C., Tanner, R., & Bhansali, S. (2011). Impedance-based miniaturized biosensor for ultrasensitive and fast prostate-specific antigen detection. Journal of Sensors, 2011, 1-7. DOI: 10.1155 /2011/983752.
36. Cummings, R. D., & Pierce, J. M. (2014). The challenge and promise of glycomics. Chemistry & Biology, 21, 1-15. DOI: 10.1016/j.chembiol.2013.12.010.
37. Dalziel, M., Crispin, M. , Scanlan, C. N., Zitzmann, N., & Dwek, R. A. (2014). Emerging principles for the therapeutic exploitation of glycosylation. Science, 343, 1235681. DOI: 10.1126/science.1235681.
38. Daniel, M. C., & Astruc, D. (2004). Gold nanoparticles: Assembly, supramolecular chemistry, quantum-size-related properties and applications toward biology, catalysis and nanotechnology. Chemical Reviews, 104, 293-346. DOI: 10.1021/cr030698 +.
39. Daubenmier, J. J., Weidner, G., Marlin, R., Crutchfield, L., Dunn-Emke, S., Chi, C., Gao, B., Carroll, P., & Ornish, D. (2006). Lifestyle and health-related quality of life of men with prostate cancer managed with active surveillance. Urology, 67, 125-130. DOI: 10.1016/j.urology.2005.07.056.
40. Davis, J. J., Tkac, J., Laurenson, S., & Ferrigno, P. K. (2007). Peptide aptamers in label-free protein detection: 1. Characterization of the immobilized scaffold. Analytical Chemistry, 79, 1089-1096. DOI: 10.1021/ac061863z.
41. Davis, J. J., Tkac, J., Humphreys, R., Buxton, A. T., Lee, T. A., & Ferrigno, P. K. (2009). Peptide aptamers in label-free protein detection: 2. Chemical optimization and detection of distinct protein isoforms. Analytical Chemistry, 81, 3314-3320. DOI: 10.1021/ac802513n.
42. Dey, A., Kaushik, A., Arya, S. K., & Bhansali, S. (2012). Mediator free highly sensitive polyaniline-gold hybrid nanocomposite based immuno sensor for prostate-specific antigen (PSA) detection. Journal of Materials Chemistry, 22, 14763-14772. DOI: 10.1039/c2jm31663c.
43. Edwards, B.K., Brown, M. L.,Wingo, P.A.,Howe,H. L., Ward, E., Ries, L. A. G., Schrag, D., Jamison, P. M., Jemal, A., Wu, X. C., Friedman, C., Harlan, L., Warren, J., Anderson, R. N., & Pickle, L. W. (2005). Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. JNCI Journal of the National Cancer Institute, 97, 1407-1427. DOI: 10.1093/jnci/dji289.
44. Epstein, J. I., Allsbrook, W. C., Jr., Amin, M. B., & Egevad, L. L. ( 2005). The 2005 international society of urological pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma. The American Journal of Surgical Pathology, 29, 1228-1242.
45. Estrela, P., Stewa rt, A. G., Yan, F., & Migliorato, P. (2005). Field effect detection of biomolecular interactions. Electrochimica Acta, 50, 4995-5000. DOI: 10.1016/j.electacta. 2005.02.075.
46. Estrela, P., Paul, D., Li, P., Keighley, S. D., Migliorato, P., Laurenson, S., & Ferrigno, P. K. (2008). Label-free detection of protein interactions with peptide aptamers by open circuit potential measurement. Electrochimica Acta, 53, 6489-6496. DOI: 10.1016/j.electacta.2008.04.036.
47. Estrela, P., Paul, D., Song, Q., Stadler, L. K. J., Wang, L., Huq, E., Davis, J. J., Ferrigno, P. K., & Migliorato, P. (2010). Label-fr ee sub-picomolar protein detection with fieldeffect transistors. Analytical Chemistry, 82, 3531-3536. DOI: 10.1021/ac902554v.
48. Faiz, O., & Moffat, D. (2002). Anatomy at a glance (pp. 176). Oxford, UK: Blackwell.
49. Ferlay, J., & Soerjomataram, I. (2013). Globocan 2012 V1.0, cancer incidence and mortality worldwide: Iarc cancerbase no. 11. Retrieved April 28, 2014, from http://globocan.iarc.fr
50. Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J. W. W., Comber, H., Forman, D., & Bray, F. (2013). Cancer incidence and mortality patterns in Europe: Estimates for 40 countrie s in 2012. European Journal of Cancer, 49, 1374-1403. DOI: 10.1016/j.ejca.2012.12.027.
51. Fletcher, R. H., Fletcher, S. W., & Fletcher, G. S. (2012). Clinical epidemiology: The essentials. Philadelphia, PA, USA: Lippincott Williams & Wilkins.
52. Freeze, H. H., & Ng, B. G. (2012). Glycomics, glycobiology and glyco-medicine. In G. S. Ginsburg, & H. F. Willard (Eds.), Genomic and personalized medicine (pp. 173). Ams terdam, The Netherlands: Elsevier.
53. Fujita, K., Shimomura, M., Uemura, M., Nakata, W., Sato, M., Nagahara, A., Nakai, Y., Takamatsu, S., Miyoshi, E., & Nonomura, N. (2014). Serum fucosylated haptoglobin as a novel prognostic biomarker predicting high-Gleason prostate cancer. The Prostate, 74, 1052-1058. DOI: 10.1002/pros. 22824.
54. Gabius, H. J., Andre, S., Kaltner, H., & Siebert, H. C. (2002). The sugar code: Functional lectinomics. Biochimica et Biophysica Acta (BBA)-General Subjects, 1572, 165-177. DOI: 10.1016/s0304-4165(02)00306-9.
55. Geissner A. Anish C. Seeberger P. H. 2014 Glycan arrays as tools for infectious disease research Current Opinion in Chemical Biology 18 38-45 10.1016/j.cbpa.2013. 11.013.
56. Gemeine r, P., Mislovi?ova, D., Tka?, J., Švitel, J., Patoprsty, V., Hrabarova, E., Kogan, G., & Ko? ar, T. (2009). Lectinomics: II. A highway to biomedical/clinical diagnostics. Biotechnology Advances, 27, 1-15. DOI: 10.1016/j.biotechadv.2008.07. 003.
57. Gilgunn, S., Conroy, P. J., Saldova, R., Rudd, P. M., & O'Kennedy, R. J. (2013). Aberrant PSA glycosylation-A sweet predictor of prostate cancer. Nature Reviews Urology, 10, 99-107. DOI: 10.1038/nrurol.2012.258.
58. Gooding, J. J., Mearns, F., Yang, W., & Liu, J. Q. (2003). Self-assembled monolayers into the 21st century: Recent advances and applications. Electroanalysis, 15, 81-96. DOI: 10.1002/elan.200390017.
59. Gopinath, S. C. B., Tang, T. H., Citartan, M., Chen, Y., & Lakshmipriya, T. (2014). Current aspects in immunosensors. Biosensors and Bioelectronics, 57, 29 2-302. DOI: 10.1016/j.bios.2014.02.029.
60. Gray, C. J., Weissenborn, M. J., Eyers, C. E., & Flitsch, S. L. (2013). Enzymatic reactions on immobilised substrates. Chemical Society Reviews, 42, 6378-6405. DOI: 10.1039/c3cs60018a.
61. Grossmann, M., Cheung, A. S., & Zajac, J. D. (2013). Androgens and prostate cancer; pathogenesis and deprivation therapy. Best Practice & Research Clinical Endocrinology & Metabolism, 27, 603-616. DOI: 10.1016/j.beem.2013.05.001.
62. Gu, Z., Thomas, G., Yamashiro, J., Shintaku, I. P., Dorey, F., Raitano, A., Witte, O. N., Said, J. W., Loda, M., & Reiter, R. E. (2000). Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer. Oncogene, 19, 1288-1296. DOI: 10.1038/sj.onc.1203426.
63. Gunia, S., Koch, S. , May, M., Dietel, M., & Erbersdobler, A. (2009). Expression of prostatic acid phosphatase (PSAP) in transurethral resection specimens of the prostate is predictive of histopathologic tumor stage in subsequent radical prostatectom ies. Virchows Archiv, 454, 573-579. DOI: 10.1007/s00428-009-0759-1.
64. Guo, Q.M., & Li, F. S. (2014). Self-assembled alkanethiol monolayers on gold surfaces: Resolving the complex structure at the interface by STM. Physical Chemistry Chemical Physics, 16, 19074-19090. DOI: 10.1039/c4cp00596a.
65. Gupta-Elera, G., Garrett, A. R., Robison, R. A., & O'Neill, K. L. (2012). The role of oxidative stress in prostate ca ncer. European Journal of Cancer Prevention, 21, 155-162. DOI: 10.1097/cej.0b013e32834a8002.
66. Gutman, A. B., & Gutman, E. B. (1938). An " acid" phosphatase occurring in the serum of patients with metastasizing carcinoma of the prostate gland. Journal of Clinical Investigation, 17, 473-478. DOI: 10.1172/jci100974.
67. Haltiwanger, R. S., & Lowe, J. B. (2004). Role of glycosylation in development. Annual Review of Biochemistry, 73, 491-537. DOI: 10.1146/annurev.biochem.73.011303.074043.
68. Hart, G. W., & Copeland, R. J. (2010). Glycomics hits the big time. Cell, 143, 672-676. DOI: 10.1016/j.cell.2010.11.008.
69. Healy, D. A., Hayes, C. J., Leonard, P., McKenna, L., & O'Kennedy, R. (2007). Biosensor developments: Application to prostate-specific antigen d etection. Trends in Biotechnology, 25, 125-131. DOI: 10.1016/j.tibtech.2007.01.004.
70. Hermanson, G. T. (2013). Bioconjugate techniques. Rockford, IL, USA: Academic Press.
71. Hideshima, S., Kuroiwa, S., Kimura, M., Cheng, S., & Osaka, T. (2013). Effect of the size of receptor in allergy detection using field effect transistor biosensor. Electrochimica Acta, 110, 146-151. DOI: 10.1016/j.electacta.2013. 07.113.
72. Hirabayashi, J., Yamada, M., Kuno, A., & Tateno, H. (2013). Lectin microarrays: Concept, principle and applications. Chemical Society Reviews, 42, 4443-4458. DOI: 10.1039/c3cs35419a.
73. Holliger, P., & Hudson, P. J. (2005). Engineered antibody fragments and the rise of single domains. Nature Biotechnology, 23, 1126-1136. DOI: 10.1038/nbt1142.
74. Holmes, E. H., Greene, T. G., Tino, W. T., Boynton, A. L., Aldape, H. C., Misrock, S. L., & Murphy, G. P. (1996). Analysis of glycosylation of prostate-specific membrane antigen derived from lncap cells, prostatic carcinoma tumors, and serum from prostate cancer patients. The Prostate, 29(Supplement 7), 25-29. DOI: 10.1002/(sici)1097-0045(1996)7+3.0.co;2-i.
75. Huang, Y. W., Wu, C. S., Chuang, C. K., Pang, S. T., Pan, T. M., Yang, Y. S., & Ko, F. H. (2013). Real-time and label-free detection of the prostate-specific antigen in human serum by a polycrystalline silicon nanowire field-effect transistor biosensor. Analytical Chemistry, 85, 7912-7918. DOI: 10.1021/a c401610s.
76. Hushegyi A. Tkac J. 2014 Are glycan biosensors an alternative to glycan microarrays? Analytical Methods6 6610-6620 10.1039/c4ay00692e.
77. Jimenez-Andrade, J. M., Manty h, W. G., Bloom, A. P., Ferng, A. S., Geffre, C. P., & Mantyh, P. W. (2010). Bone cancer pain. Annals of the New York Academy of Sciences, 1198, 173-181. DOI: 10.1111/j.1749-6632.2009.05429.x.
78. Katrl ik, J., Švitel, J., Gemeiner, P., Ko? ar, T., & Tkac, J. (2010). Glycan and lectin microarrays for glycomics and medicinal applications. Medicinal Research Reviews, 30, 394-418. DOI: 10.1002/med.20195.
79. Katz, E. , & Willner, I. (2003). Probing biomolecular interactions at conductive and semiconductive surfaces by impedance spectroscopy: Routes to impedimetric immune sensors, DNA-sensors and enzyme biosensors. Electroanalysis, 15, 913-947. DOI: 10.1002/elan.200390114.
80. Kavosi, B., Salimi, A., Hallaj, R., & Amani, K. (2014). A highly sensitive prostate-specific antigen immunosensor based on gold nanoparticles/PAMAM dendrimer loaded on MWCNTS/chitosan/ionic liquid nanocomposite. Biosensors and Bioelectronics, 52, 20-28. DOI: 10.1016/j.bios.2013.08.012.
81. Kim, E. H., & Misek, D. E. (2011). Glycoproteomics-based identification of cancer biomarkers. International Journal of Proteomics, 2011, 1-10. DOI: 10.1155/2011/601937.
82. Kim, J. H., Resende, R., Wennekes, T., Chen, H. M., Bance, N., Buchini, S., Watts, A. G., Pilling, P., Streltsov, V. A., Petric, M., Liggins, R., Barrett, S., McKimm-Breschkin, J. L., Niikura, M., & Withers, S. G. (2013). Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity. Science, 340, 71-75. DOI: 10.1126/science. 123255 2.
83. Klukova, ?., Bertok, T., Kasak, P., & Tkac, J. (2014). Nanoscale-controlled architecture for the development of ultrasensitive lectin biosensors applicable in glycomics. Analytical Methods, 6, 4922-4931 DOI: 10.1039/c4ay 00495g.
84. Knedlik, T., Navratil, V., Vik, V., Pacik, D., Šacha, P., & Konvalinka, J. (2014). Detection and quantitation of glutamate carboxypeptidase II in human blood. The Prostate, 74, 768-780. DOI: 10.1002/pros.22796.
85. Kong, H. Y., & Byun, J. (2013). Emerging roles of human prostatic acid phosphatase. Biomolecules and Therapeutics, 21, 10-20. DOI: 10.4062/biomolther.2012.095.
86. Kral, M., Rosinska, V., Student, V., Grepl, M., Hrabec, M., & Bouchal, J. (2011). Genetic determinants of prostate cancer: A review. Biomedical Papers, 155, 3-10. DOI: 10.5507/bp.155.2011.001.
87. Langmuir , I. (1917). The constitution and fundamental properties of solids and liquids II. Liquids. Journal of the American Chemical Society, 39, 1848-1906. DOI: 10.1021/ja02254a006.
88. Laurent, N., Haddoub, R., & Flitsch, S. L. (2008). Enzyme catalysis on solid surfaces. Trends in Biotechnology, 26, 328-337. DOI: 10.1016/j.tibtech.2008.03.003.
89. Leissner, K. H., & Tisell, L. E. (1979). The weight of the human prostate. Scandinavian Journal of Urology and Nephrology, 13, 137-142. DOI: 10.3109/00365597909181168.
90. Lepenies, B., & Seeberger, P. H. (2014). Simply better glycoproteins. Nature Biotechnology, 32, 443-445. DOI: 10.1038/nbt.2893.
91. Lepor, H. (2004). Pathophysiology, epidemiology and natural history of benign prostatic hyperplasia. Reviews in Urology, 6, S3-S10.
92. Love, J. C., Estroff, L. A., Kriebel, J. K., Nuzzo, R. G., &Whitesides, G. M. (2005). Self-assembled monolayers of thiolates on metals as a form of nanotechnology. Chemical Reviews, 105, 1103-1170. DOI: 10.102 1/cr0300789.
93. Luo, X. L., Morrin, A., Killard, A. J., & Smyth, M. R. (2006). Application of nanoparticles in electrochemical sensors and biosensors. Electroanalysis, 18, 319-326. DOI: 10.1002/ela n.200503415.
94. Luo, X. L., & Davis, J. J. (2013). Electrical biosensors and the label free detection of protein disease biomarkers. Chemical Society Reviews, 42, 5944-5962. DOI: 10.1039/c3cs60077g.
95. Lvovich, V. F. (2012). Impedance spectroscopy: Applications to electrochemical and dielectric phenomena. Hoboken, NJ, USA: Wiley. DOI: 10.1002/9781118164075.ch13.
96. MacDonald, J. R., & Johnson, W. B. (2005). Fundamentals of impedance spectroscopy. In E. Barsoukov, & J. R. MacDonald (Eds.), Impedance spectroscopy: Theory, experiment and applications (pp. 8). Hoboken, NJ, USA: Wiley.
97. Madu, C. O., & Lu, Y. (2010). Novel diagnostic biomarkers for prostate cancer. Journal of Cancer, 1, 150-177.
98. Mandler D. Kraus-Ophir S. 2011 Self-assembled monolayers (SAMs) for el ectrochemical sensingJournal of Solid State Electrochemistry 15 1535-1558 10.1007/s10008-011-1493-6.
99. Mari? no, K., Bones, J., Kattla, J. J., & Rudd, P. M. (2010). A systematic approach to protein glycosylation analysis: A path through the maze. Nature Chemical Biology, 6, 713-723. DOI: 10.1038/nchembio.437.
100. Martin, D. N., Starks, A. M., & Ambs, S. (2013). Biological determinants of health di sparities in prostate cancer. Current Opinion in Oncology, 25, 235-241. DOI: 10.1097/cco.0b013e32835eb5d1.
101. Matsumoto, A., & Miyahara, Y. (2013). Current and emerging challenges of field effect transistor based bio-sensing. Nanoscale, 5, 10702-10718. DOI: 10.1039/c3nr02703a.
102. Mechref, Y., Hu, Y. L., Garcia, A., & Hussein, A. (2012). Identifying cancer biomarkers by mass spectrometry-based glycomics. Electrophor esis, 33, 1755-1767. DOI: 10.1002/elps. 201100715.
103. Mellinger, G. T., Gleason, D., & Bailar, J., 3rd. (1967). The histology and prognosis of prostatic cancer. The Journal of Urology, 97, 331-337.
104. Meyburg, S., Stockmann, R., Moers, J., Offenhausser, A., & Ingebrandt, S. (2007). Advanced CMOS process for floating gate field-effect transistors in bioelectronic applications. Sensors and Actuat ors B: Chemical, 128, 208-217. DOI: 10.1016/j.snb.2007.06.003.
105. Mikolajczyk, S. D., Grauer, L. S., Millar, L. S., Hill, T. M., Kumar, A., Rittenhouse, H. G., Wolfert, R. L., & Saedi, M. S. (1997). A precursor form of PSA (pPSA) is a component of the free PSA in prostate cancer serum. Urology, 50, 710-714. DOI: 10.1016/s0090-4295(97)00449-4.
106. Miller, D. C., Hafez, K. S., Stewart, A., Mont ie, J. E., & Wei, J. T. (2003). Prostate carcinoma presentation, diagnosis and staging. Cancer, 98, 1169-1178. DOI: 10.1002/cncr.11635.
107. Miller, J., & Tarter, T. H. (2009). Combination therapy with dutasteride and tamsulosin for the treatment of symptomatic enlarged prostate. Clinical Interventions in Aging, 2009, 251-258. DOI: 10.2147/cia.s4102.
108. Mislovi?ova, D., Gemeiner, P., Kozarova, A., & Ko? ar, T. (2009). Lectinomics I. Relevance of exogenous plant lectins in biomedical diagnostics. Biologia, 64, 1-19. DOI: 10.2478/s11756-009-0029-3.
109. Moon, J. M., Kim, Y. H., & Cho, Y. N. (2014). A na nowirebased label-free immunosensor: Direct incorporation of a PSA antibody in electropolymerized polypyrrole. Biosensors and Bioelectronics, 57, 157-161. DOI: 10.1016/j.bios.2014. 02.016.
110. Mu, B., Zhang, J. Q., McNi cholas, T. P., Reuel, N. F., Kruss, S., & Strano, M. S. (2014). Recent advances in molecular recognition based on nanoengineered platforms. Accounts of Chemical Research, 47, 979-988. DOI: 10.1021/ar400162w.
111. Muniyan, S., Chaturvedi, N. K., Dwyer, J. G., LaGrange, C. A., Chaney, W. G., & Lin, M. F. (2013). Human prostatic acid phosphatase: Structure, function and regulation. International Journal of Molecular Sciences, 14, 10438-10464. DOI: 10.3390/ijms140510438.
112. Muniyan, S., Ingersoll, M. A., Batra, S. K., & Lin, M. F. (2014). Cellular prostatic acid phosphatase, a PTENfunctional homologue in prostate epithelia, fun ctions as a prostate-specific tumor suppressor. Biochimica et Biophysica Acta (BBA)-General Subjects, 1846, 88-98. DOI: 10.1016/j.bbcan.2014.04.006.
113. Murphy, K. P., Travers, P., Walport, M., & Janeway, C. (2008). Janeway's immunobiology. New York, NY, USA: Garland Science.
114. Nagatsuka, T., Uzawa, H., Sato, K., Kondo, S., Izumi, M., Yokoyama, K., Ohsawa, I., Seto, Y., Neri, P., Mori, H., Ni shida, Y., Saito, M., & Tamiya, E. (2013). Localized surface plasmon resonance detection of biological toxins using cell surface oligosaccharides on glyco chips. ACS Applied Materials & Interfaces, 5, 4173-4180. DOI: 10.1021/am4002937.
115. Nakayama, Y., Nakamura, N., Tsuji, D., Itoh, K., & Kurosaka, A. (2013). Genetic diseases associated with protein glycosylation disorders in mammals. In M. Puiu (Ed.), Genetic disorders. R ijeka, Croatia: InTech. DOI: 10.5772/54097.
116. National Cancer Institute (2014). NCI Dictionary of cancer terms. Retrieved on June 2014, from http://www.cancer.gov/
117. Novotny, M. V., & Alley, W. R., Jr. (2013). Recent trends in analytical and structural glycobiology. Current Opinion in Chemical Biology, 17, 832-840. DOI: 10.1016/j.cbpa.2013.05. 029.
118. Ostrowski, W. S., & Kuciel, R. (1994). Human prostatic acid phosphatase: Selected properties and practical applications. Clinica Chimica Acta, 226, 121-129. DOI: 10.1016/0009-8981(94)90209-7.
119. Owen, D. H., & Katz, D. F. (2005). A review of the physical and chemical properties of hum an semen and the formulation of a semen simulant. Journal of Andrology, 26, 459-469. DOI: 10.2164/jandrol.04104.
120. Pale?ek, E., Tkac, J., Barto?ik M., Bertok, T., Ostatna, V., & Pale?ek, J.(2014). Elec trochemistry of non-conjugated proteins and glycoproteins. towards sensors for biomedicine and glycomics. Chemical Reviews, Submitted.
121. Pepe, M. S., Etzioni, R., Feng, Z. D., Potter, J. D., Thompson, M. L., Thornquist, M. , Winget, M., & Yasui, Y. (2001). Phases of biomarker development for early detection of cancer. Journal of the National Cancer Institute, 93, 1054-1061.
122. Peracaula, R., Tabares, G., Royle, L., Harvey, D. J., Dwek, R. A., Rudd, P. M., & De Llorens, R. (2003). Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins. Glycobiology, 13, 45 7-470. DOI: 10.1093/glycob/cwg041.
123. Peracaula, R., Barrabes, S., Sarrats, A., Rudd, P. M., & De Llorens, R. (2008). Altered glycosylation in tumours focused to cancer diagnosis. Disease Markers, 25, 207-218. DOI: 10.1155/2008/797629.
124. Perumal, V., & Hashim, U. (2014). Advances in biosensors: Principle, architecture and applications. Journal of Applied Biomedicine, 12, 1-15. DOI: 10.1016/j.jab.2013.02.001.
125. Poon, C. Y., Chan, H. M., & Li, H. W. (2014). Direct detection of prostate specific antigen by darkfield microscopy using single immunotargeting silver nanoparticle. Sensors and Actuators B: Chemical, 190, 737-744. DOI: 10.1016/j.snb.2013.09.057.
126. Prensner, J. R., Rubin, M. A., Wei, J. T., & Chinnaiyan, A. M. (2012). Beyond PSA: The next generation of prostate cancer biomarkers. Science Translational Medicine, 4, 127rv123. DOI: 10.1126/scitranslmed.3003180.
127. Purcell, A. W., Van Driel, I. R., & Gleeson, P. A. (2008). Impact of glycans on T-cell tolerance to glycosylated selfantigens. Immunology and Cell Biology, 86, 574-579. DOI: 10.1038/icb.2008.48.
128. Qu, B., Guo, L., Chu, X., Wu, D. H., Shen, G. L., & Yu, R. Q. (2010). An electrochemical immunosensor based on enzyme-encapsulated liposomes and biocatalytic metal deposition. Analytica Chimica Acta, 663, 147-152. DOI: 10.1016/j.aca.2010.01.050.
129. Raff, A. B., Gray, A., & Kast, W. M. (2009). Prostate stem cell antigen: A prospective therapeutic and diagnostic target. Cancer Letters, 277, 126-132. DOI: 10.1016/j.canlet.2008. 08.034.
130. R eiter, R. E., Gu, Z. N., Watabe, T., Thomas, G., Szigeti, K., Davis, E., Wahl, M., Nisitani, S., Yamashiro, J., Le Beau, M. M., Loda, M., & Witte, O. N. (1998). Prostate stem cell antigen: A cell su rface marker overexpressed in prostate cancer. Proceedings of the National Academy of Sciences of the United States of America, 95, 1735-1740.
131. Reuel, N. F., Mu, B., Zhang, J. Q., Hinckley, A., & Strano, M. S. (2012). Nanoengineered glycan sensors enabling native glycoprofiling for medicinal applications: Towards profiling glycoproteins without labeling or liberation steps. Chemical Society Reviews, 41, 5744-5779. DOI: 10.1039/c2cs351 42k.
132. Reuel, N. F., Grassbaugh, B., Kruss, S., Mundy, J. Z., Opel, C., Ogunniyi, A. O., Egodage, K., Wahl, R., Helk, B., Zhang, J. Q., Kalcioglu, Z. I., Tvrdy, K., Bellisario, D. O., Mu, B., Blake, S. S., Van Vliet, K. J., Love, J. C., Wittrup, K. D., & Strano, M. S. (2013). Emergent properties of nanosensor arrays: Applications for monitoring IgG affinity distributions, weakly affined hypermannosylation and colo ny selection for biomanufacturing. Acs Nano, 7, 7472-7482. DOI: 10.1021/nn403215e.
133. Revenig, L., Leung, A., & Hsiao,W. (2014). Ejaculatory physiology and pathophysiology: Assessment and treatment in male infe rtility. Translational Andrology and Urology, 3, 41-49. DOI: 10.3978/j.issn.2223-4683.2014.02.02.
134. Rich, R. R., Fleisher, T. A., Shearer, W. T., Schroeder, H., Frew, A. J., & Weyand, C. M. (2013). Clinical immunology: Principles and practice (Expert consult-online and print) (4th ed.). Elsevier.
135. Rillahan, C. D., Antonopoulos, A., Lefort, C. T., Sonon, R., Azadi, P., Ley, K., Dell, A., Haslam, S. M., & Paulson, J. C. (2012). Global metabolic inhibitors of sialyl-and fucosyltransferases remodel the glycome. Nature Chemical Biology, 8, 661-668. DOI: 10.1038/nchembio.999.
136. Rudd, P. M., & Dwek, R. A. (1997). Glycosylation: Heterogeneity and the 3D structure of proteins. Critical Reviews in Biochemistry and Molecular Biology, 32, 1-100. DOI: 10.3109/10409239709085144.
137. Russell, P. J. (2006). iGenetics : A molecular approach. San Francisco, CA, USA: Benjamin Cummings.
138. Saldova, R., Royle, L., Radcliffe, C. M., Abd Hamid, U. M., Evans, R., Arnold, J. N., Banks, R. E., Hutson, R., Harvey, D. J., Antro bus, R., Petrescu, S. M., Dwek, R. A., & Rudd, P. M. (2007). Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology, 17, 1344-1356. DOI: 10.1093/glycob/c wm100.
139. Saldova, R., Fan, Y., Fitzpatrick, J. M., Watson, R. W. G., & Rudd, P. M. (2011). Core fucosylation and ?2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign pro state hyperplasia. Glycobiology, 21, 195-205. DOI: 10.1093/glycob/cwq147.
140. Salimi, A., Kavosi, B., Fathi, F., & Hallaj, R. (2013). Highly sensitive immunosensing of prostate-specific antigen based on ionic liquid-carbon nanotubes modified electrode: Application as cancer biomarker for prostate biopsi es. Biosensors and Bioelectronics, 42, 439-446. DOI: 10.1016/j.bios.2012. 10.053.
141. Sang S. B. Zhao Y. Zhang W. D. Li P. W. Hu J. Li G. 2014 Surface stress-based biosensors Biosen sors and Bioelectronics 51 124-135 10.1016/j.bios.2013.07.033.
142. Sarrats, A., Saldova, R., Comet, J., O'Donoghue, N., De Llorens, R., Rudd, P. M., & Peracaula, R. (2010). Glycan charac terization of PSA 2-DE subforms from serum and seminal plasma. OMICS: A Journal of Integrative Biology, 14, 465-474. DOI: 10.1089/omi.2010.0050.
143. Sawyers, C. L. (2008). The cancer biomarker problem. Nature, 452, 548-552. DOI: 10.1038/nature06913.
144. Schachter, H., & Freeze, H. H. (2009). Glycosylation diseases: Quo vadis? Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1792, 925-930. DOI: 10.1016/j.bbadis. 2008.11.002.
145. Shen, G. G., Cai, C. B., & Yang, J. F. (2011). Fabrication of an electrochemical immunosensor based on a gold-hydroxyapatite nanocomposite-chitosan film. Electrochimica Acta, 5 6, 8272-8277. DOI: 10.1016/j.electacta.2011.06.090.
146. Shen, C. H., & Lin, J. C. (2013). Solvent and concentration effects on the surface characteristics and platelet compatibility of zwitterionic sulfobetaine-terminat ed self-assembled monolayers. Colloids and Surfaces B: Biointerfaces, 101, 376-383. DOI: 10.1016/j.colsurfb.2012.07.035.
147. Siegel, R., DeSantis, C., Virgo, K., Stein, K., Mariotto, A., Smith, T., Coope r, D., Gansler, T., Lerro, C., Fedewa, S., Lin, C. C., Leach, C., Cannady, R. S., Cho, H. S., Scoppa, S., Hachey, M., Kirch, R., Jemal, A., & Ward, E. (2012a). Cancer treatment and survivorship stat istics, 2012. CA: A Cancer Journal for Clinicians, 62, 220-241. DOI: 10.3322/caac.21149.
148. Siegel, R., Naishadham, D., & Jemal, A. (2012b). Cancer statistics, 2012. CA: A Cancer Journal for Clinicians, 62, 10-29. DOI: 10.3322/caac.20138.
149. Solis, D., Bovin, N. V., Davis, A. P., Jimenez-Barbero, J., Romero, A., Roy, R., Smetana, K., Jr., & Gabius, H. J. (2014). A guide into glycoscienc es: How chemistry, biochemistry and biology cooperate to crack the sugar code. Biochimica et Biophysica Acta (BBA)-General Subjects, in press. DOI: 10.1016/j.bbagen.2014.03.016.
150. Song, R. J., Oren, D. A., Franco, D., Se aman, M. S., & Ho, D. D. (2013). Strategic addition of an N-linked glycan to a monoclonal antibody improves its HIV-1-neutralizing activity. Nature Biotechnology, 31, 1047-1052. DOI: 10.1038/nbt.2677.
151. Sparbier, K., Koch, S., Kessler, I., Wenzel, T., & Kostrzewa, M. (2005). Selective isolation of glycoproteins and glycopeptides for MALDI-TOF MS detection supported by magnetic particles. Journal of Biomolecular Techniques, 1 6, 407-413.
152. Suaifan, G. A. R. Y., Esseghaier, C., Ng, A., & Zourob, M. (2012). Wash-less and highly sensitive assay for prostate specific antigen detection. The Analyst, 137, 5614-5619. DOI: 10.10 39/c2an36243k.
153. Susloparova, A., Koppenhöfer, D., Vu, X. T., Weil, M., & Ingebrandt, S. (2013). Impedance spectroscopy with field-effect transistor arrays for the analysis of anti-cancer drug action on individual ce lls. Biosensors and Bioelectronics, 40, 50-56. DOI: 10.1016/j.bios.2012.06.006.
154. Svarovsky, S. A., & Joshi, L. (2014). Cancer glycan biomarkers and their detection-past, present and future. Analytical Methods, 6, 3918-3936. DOI: 10.1039/c3ay42243g.
155. Szunerits, S., Maalouli, N.,W ijaya, E., Vilcot, J. P., & Boukherroub, R. (2013). Recent advances in the development of graphene-based surface plasmon resonance (SPR) interfaces. Analytical and Bioanalytical Chemistry, 405, 1435-1443. DOI: 10.1007/s00 216-012-6624-0.
156. Tabares, G., Radcliffe, C. M., Barrabes, S., Ramirez, M., Aleixandre, R. N., Hoesel, W., Dwek, R. A., Rudd, P. M., Peracaula, R., & De Llorens, R. (2006). Different glycan stru ctures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA. Glycobiology, 16, 132-145. DOI: 10.1093/glycob/cwj042.
157. Tabesh, A., Teverovskiy, M., Pang, H. Y., Kumar, V. P. , Verbel, D., Kotsianti, A., & Saidi, O. (2007). Multifeature prostate cancer diagnosis and gleason grading of histological images. IEEE Transactions on Medical Imaging, 26, 1366-1378. DOI: 10.1109/tmi.2 007.898536.
158. Taira, A., Merrick, G.,Wallner, K., & Dattoli, M. (2007). Reviving the acid phosphatase test for prostate cancer. Oncology, 21, 1003-1010.
159. Tajiri, M., Ohyama, C., & Wada, Y. (2008). Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: A glycopeptide approach. Glycobiology, 18, 2-8. DOI: 10.1 093/glycob/cwm117.
160. Tamayo, J., Kosaka, P. M., Ruz, J. J., San Paulo, A., & Calleja, M. (2013). Biosensors based on nanomechanical systems. Chemical Society Reviews, 42, 1287-1311. DOI: 10.1039/c2cs35 293a.
161. Tian, J. N., Huang, J. L., Zhao, Y. C., & Zhao, S. L. (2012). Electrochemical immunosensor for prostate-specific antigen using a glassy carbon electrode modified with a nanocomposite containing gold nanoparticles supported with starchfunctionalized multi-walled carbon nanotubes. Microchimica Acta, 178, 81-88. DOI: 10.1007/s00604-012-0816-3.
162. Tkac, J., & Davis, J. J. (2009). Label-free field effect protein sensing. In J. Davis (Ed.), Engineering the bioelectronic interface: Applications to analyte biosensing and protein detection (pp. 193-224). Cambridge, UK: Royal Society of Chemistry. DOI: 10.1039/9781847559777-00193.
163. Tkac J. Bert ok, T. Nahalka, J., Gemeiner, P. 2014 Perspectives in glycomics and lectin engineering In J. Hirabayashi (Ed.) Methods in molecular biology (pp. 421-445). New York, NY, USA Springer 10.1007/978-1-4939-1292-6 37
164. Tousi, F., Hancock, W. S., & Hincapie, M. (2011). Technologies and strategies for glycoproteomics and glycomics and their application to clinical biomarker research. Analytical Methods, 3, 20-32. DOI : 10.1039/c0ay00413h.
165. Ueda, K., Tatsuguchi, A., Saichi, N., Toyama, A., Tamura, K., Furihata, M., Takata, R., Akamatsu, S., Igarashi, M., Nakayama, M., Sato, T. A., Ogawa, O., Fujioka, T., Shuin, T., Nakamura, Y., & Nakagawa, H. (2013). Plasma lowmolecular-weight proteome profiling identified neuropeptide-Y as a prostate cancer biomarker polypeptide. Journal of Proteome Research, 12, 4497-4506. DOI: 1 0.1021/pr400547s.
166. Varki, A., & Chrispeels, M. J. (1999). Essentials of glycobiology. New York, NY, USA: Cold Spring Harbor.
167. Vector Laboratories (2012). Table of lectin properties. Retrieved on June 2014, from https://www.vectorlabs.com/data/brochures/K4-K7.pdf
168. Vegvari, A., Rezeli, M., Sihlbom, C., Hakkinen, J., Carlsohn, E., Malm, J., Lilja, H., Laurell, T., & Marko-Varga, G. (2012). Molecular microheterogeneity of prostate specific antigen in seminal fluid by ma ss spectrometry. Clinical Biochemistry, 45, 331-338. DOI: 10.1016/j.clinbiochem.2011.11.018.
169. Vis, A. N., & Schröder, F. H. (2009). Key targets of hormonal treatment of prostate cancer. Part 1: The androgen receptor and steroidogenic pathways. BJU International, 104, 438-448. DOI: 10.1111/j.1464-410x.2009.08695.x.
170. Vollmer, R. T., & Humphrey, P. A. (2001). The relative importance of anatomic and PSA factors to outcomes after radical prostatectomy for prostate cancer. American Journal of Clinical Pathology, 116, 864-870. DOI: 10.1309/7mq7-mwar-4w8a-r75f.
171. Wang, J. P., & Yau, S. T. (2013). Detection of prostate specific antigen in serum at the femto-gram per milliliter level using the intrinsic amplification of a field-effect enzymatic immuno-sensing system. Electrochimica Acta, 11 1, 92-98. DOI: 10.1016/j.electacta.2013.08.046.
172. Wang, Z., Chinoy, Z. S., Ambre, S. G., Peng, W., McBride, R., De Vries, R. P., Glushka, J., Paulson, J. C., & Boons, G. J. (2013a). A gener al strategy for the chemoenzymatic synthesis of asymmetrically branched N-glycans. Science, 341, 379-383. DOI: 10.1126/science.1236231.
173. Wang, H., Zhang, Y., Yu, H. Q., Wu, D., Ma, H. M., Li, H., Du, B., & Wei, Q. (2013b). Label-free electrochemical immunosensor for prostate-specific antigen based on silver hybridized mesoporous silica nanoparticles. Analytical Biochemistry, 434, 123-127. DOI: 10.1016/j.ab.2012. 11.012.
174. Wang, K., Fan, D. D., Jin, S., Xing, N. Z., & Niu, Y. N. (2014). Differential expression of 5-alpha reductase isozymes in the prostate and its clinical implications. Asian Journal of Andrology, 16, 274-279. DOI: 10.4103/1008-682x.123664.
175. WebPathology (2014). Prostate. Retrieved on June 2014, from http://www.webpathology.com
176. White, K. Y., Rodemich, L., Nyalwidhe, J. O., Comunale, M. A. , Clements, M. A., Lance, R. S., Schellhammer, P. F., Mehta, A. S., Semmes, O. J., & Drake, R. R. (2009). Glycomic characterization of prostate-specific antigen and prostatic acid phosphatase in prostate cancer and ben ign disease seminal plasma fluids. Journal of Proteome Research, 8, 620-630. DOI: 10.1021/pr8007545.
177. Wu, G. H., Datar, R. H., Hansen, K. M., Thundat, T., Cote, R. J., & Majumdar, A. (2001). Bioassay of prostate-specific antigen (PSA) using microcantilevers. Nature Biotechnology, 19, 856-860. DOI: 10.1038/nbt0901-856.
178. Xu, S. J., Liu, Y., Wang, T. H., & Li, J. H. (2011). Positive po tential operation of a cathodic electrogenerated chemiluminescence immunosensor based on luminol and graphene for cancer biomarker detection. Analytical Chemistry, 83, 3817-3823. DOI: 10.1021/ac200237j.
179. Xu, Q., & Da vis, J. J. (2014). The diagnostic utility of electrochemical impedance. Electroanalysis, 26, 1249-1258. DOI: 10.1002/elan.201400035.
180. Xu, J. J., Zhao, W. W., Song, S. P., Fan, C. H., & Chen, H. Y. (2014). Functional nanoprobes for ultrasensitive detection of biomolecules: An update. Chemical Society Reviews, 43, 1601-1611. DOI: 10.1039/c3cs60277j.
181. Yang, L., Biswas, M. E., & Chen, P. (2003). St udy of binding between protein A and immunoglobulin G using a surface tension probe. Biophysical Journal, 84, 509-522. DOI: 10.1016/s0006-3495(03)74870-x.
182. Yang, M. H., Javadi, A., Li, H., & Gong, S. Q. (2010). Ultrasensitive immunosensor for the detection of cancer biomarker based on graphene sheet. Biosensors and Bioelectronics, 26, 560-565. DOI: 10.1016/j.bios.201 0.07.040.
183. Yang, M. H., Javadi, A., & Gong, S. Q. (2011). Sensitive electrochemical immunosensor for the detection of cancer biomarker using quantum dot functionalized graphene sheets as labels. Sensors and Actuators B: Chemi cal, 155, 357-360. DOI: 10.1016/j.snb.2010.11.055.
184. Yoshida K. Krasznai Z. T. Krasznai Z. Yoshiike M. Kawano N. Yoshida M. Morisawa M. Toth Z. Bazsane Z. K. Marian T. & Iwamoto, T. 2009 Functional implications of membrane modification with semenogelins for inhibition of sperm motility in humans Cell Motility and the Cytoskeleton 66 99-108 10.1002/cm.20329.
185. Yuan, Y., Yuan, R., Chai, Y. Q., Zhuo, Y., Bai, L. J., & Liao, Y. H. (2010). An electrochemical enzyme bioaffinity electrode based on biotin-streptavidin conjunction and bienzyme substrate recycling for amplification. Analyt ical Biochemistry, 405, 121-126. DOI: 10.1016/j.ab.2010.05.025.
186. Zeng, X. Q., Shen, Z. H., & Mernaugh, R. (2012a). Recombinant antibodies and their use in biosensors. Analytical and Bioanalytical Chemist ry, 402, 3027-3038. DOI: 10.1007/s00216-011-5569-z.
187. Zeng, X. Q., Andrade, C. A. S., Oliveira, M. D. L., & Sun, X. L. (2012b). Carbohydrate-protein interactions and their biosensing applications. An alytical and Bioanalytical Chemistry, 402, 3161-3176. DOI: 10.1007/s00216-011-5594-y.
188. Zeng, S. W., Baillargeat, D., Ho, H. P., & Yong, K. T. (2014). Nanomaterials enhanced surface plasmon resonance for biological and chemical sensing applications. Chemical Society Reviews, 43, 3426-3452. DOI: 10.1039/c3cs60479a.
189. Zhao, N., He, Y. Q., Mao, X., Sun, Y. H., Zhang, X. B., Li, C. Z., Lin, Y. H., & Liu, G. D. (2010). Electrochemical assay of active prostate-specific antigen (PSA) using ferrocenefunctionalized peptide probes. Electrochemistry Communications, 12, 471-474. DOI: 10.1016/j.elecom.2010.01.022.
190. Zhu, L., Jaamaa, S., af Hallström, T. M., Laiho, M., Sankila, A., Nordling, S., Stenman, U. H., & Koistinen, H. (2013). PSA forms complexes with ?1-antichymotrypsin in prostate. The Prostate, 73, 219-226. DOI: 10.1002/pro s.22560.
191. Zylka, M. J., Sowa, N. A., Taylor-Blake, B., Twomey, M. A., Herrala, A., Voikar, V., & Vihko, P. (2008). Prostatic acid phosphatase is an ectonucleotidase and suppresses pain by generating adeno sine. Neuron, 60, 111-122. DOI: 10.1016/j.neuron.2008.08.024.